awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q57266579-AA0FD129-A854-46E8-B39C-E082DA539132
Q57266579-AA0FD129-A854-46E8-B39C-E082DA539132
BestRank
Statement
http://www.wikidata.org/entity/statement/Q57266579-AA0FD129-A854-46E8-B39C-E082DA539132
Consensus recommendations for current treatments and accelerating clinical trials for patients with neurofibromatosis type 2
P2860
Q57266579-AA0FD129-A854-46E8-B39C-E082DA539132
BestRank
Statement
http://www.wikidata.org/entity/statement/Q57266579-AA0FD129-A854-46E8-B39C-E082DA539132
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
32dee03ff433ae59920043d1e7a7cdab4984da1e
P2860
Erlotinib for progressive vestibular schwannoma in neurofibromatosis 2 patients.